$SANA News

Sana Biotechnology Announces Aggregate Sales Of 21,607,878 Shares With Net Proceeds Of ~$69M Through Its ATM Facility Established With TD Securities

Sana Biotechnology, Inc. (SANA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Sana Biotechnology Presents Preclinical Data Showing Surrogate SG293 Achieves Cell-Specific Delivery, Dose-Dependent CAR T Cell Generation, And Deep B Cell Depletion In NHPs At ASGCT 2026 Annual Meeting

Sana Biotechnology Q1 Adj. EPS $(0.14) Beats $(0.17) Estimate

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data From SG293 In Vivo CAR T Product Candidate At American Society Of Gene & Cell Therapy 2026 Annual Meeting May 11-15

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data From SG293 In Vivo CAR T Product Candidate At American Society Of Gene & Cell Therapy 2026 Annual Meeting May 11-15

Sana Biotechnology: Mayo Clinic Deal A Positive Step On A Long Journey

Wedbush Maintains Outperform on Sana Biotechnology, Raises Price Target to $7

Sana Biotechnology shares are trading higher after the company announced a strategic collaboration with Mayo Clinic to advance development of SC451. Also, the company sold 7.5 million shares at $3.33 per share for $25 million to Mayo Clinic.

Sana Biotechnology shares are trading higher after the company announced a strategic collaboration with Mayo Clinic to advance development of SC451. Also, the company sold 7.5 million shares at $3.33 per share for $25 million to Mayo Clinic.

Sana Biotechnology Sells 7.5M Shares At $3.33/Shares For $25M To Mayo Clinic

Sana Biotechnology Announces Strategic Collaboration With Mayo Clinic To Improve Care In Type 1 Diabetes And Accelerating Development Of SC451

Sana Biotechnology, Inc. (SANA) Presents at The Citizens Life Sciences Conference 2026 Transcript

Sana Biotechnology Announces 14-Month Follow-Up Results From Investigator-Sponsored, First-In-Human Study Transplanting UP421 Into Patient With Type 1 Diabetes Without Any Immunosuppression

Sana Biotechnology, Inc. (SANA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

HC Wainwright & Co. Maintains Buy on Sana Biotechnology, Lowers Price Target to $7

Sana Biotechnology Files Shelf Prospectus For Offering Of Securities; No Terms Disclosed

Sana Biotechnology Q4 Adj. EPS $(0.16) Misses $(0.13) Estimate

Sana Biotechnology Appoints Brian Piper CFO

Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips